Trinity Biotech (TRIB) Total Current Liabilities (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Total Current Liabilities for 9 consecutive years, with $32.1 million as the latest value for Q4 2024.
- Quarterly Total Current Liabilities rose 113.47% to $32.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $32.1 million through Dec 2024, up 113.47% year-over-year, with the annual reading at $32.1 million for FY2024, 113.47% up from the prior year.
- Total Current Liabilities hit $32.1 million in Q4 2024 for Trinity Biotech, up from $15.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $100.5 million in Q4 2021 to a low of $15.0 million in Q4 2023.
- Historically, Total Current Liabilities has averaged $38.4 million across 5 years, with a median of $27.1 million in 2020.
- Biggest five-year swings in Total Current Liabilities: surged 271.39% in 2021 and later crashed 82.75% in 2022.
- Year by year, Total Current Liabilities stood at $27.1 million in 2020, then soared by 271.39% to $100.5 million in 2021, then plummeted by 82.75% to $17.3 million in 2022, then fell by 13.29% to $15.0 million in 2023, then surged by 113.47% to $32.1 million in 2024.
- Business Quant data shows Total Current Liabilities for TRIB at $32.1 million in Q4 2024, $15.0 million in Q4 2023, and $17.3 million in Q4 2022.